Astec Lifesciences Share Price
Astec Lifesciences Share Price Today
As of 5 Jul 2026, Astec Lifesciences share price is ₹709.90. The stock opened at ₹720.00, compared to its previous close of ₹721.95. During today's trading session, Astec Lifesciences share price moved in the range of ₹707.40 to ₹730.00, with an average price of ₹718.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹513.40 and a high of ₹947.70. On the performance front, Astec Lifesciences share price has declined by 0.73% over the last six months and is down 25.08% on a year-on-year basis.
Astec Lifesciences Returns Calculator
Astec Lifesciences Shareholder Returns
Astec Lifesciences Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| UPL | 49,668.00 | 22.37 | 1.43 | 5.54% | 0.06 | 11.23% | 166.32 | 1.02% | 0.39 | 9.46 |
| PI Industries | 39,586.30 | 29.97 | 3.52 | 11.76% | 0.01 | 14.62% | 749.35 | 0.58% | 0.53 | 94.57 |
| Sumitomo Chemical India | 22,007.30 | 40.52 | 6.49 | 16.02% | 0.02 | 21.30% | 67.80 | 0.29% | 0.91 | 10.88 |
| Bayer CropScience | 1,044.38 | 27.10 | 6.30 | 15.80% | 0.03 | 20.08% | 659.90 | 1.44% | 1.81 | 153.35 |
| Sharda Cropchem | 8,042.71 | 11.81 | 2.56 | 21.71% | 0.00 | 27.03% | 321.49 | 1.68% | 1.47 | 75.07 |
| NACL Industries | 5,004.61 | 1,068.25 | 7.33 | 2.49% | 0.42 | 7.39% | 31.39 | 0.00% | 1.96 | 1.04 |
| Dhanuka Agritech | 4,850.34 | 19.62 | 4.15 | 22.34% | 0.02 | 28.43% | 377.26 | 0.19% | 1.17 | 63.72 |
| Rallis India | 4,627.39 | 28.19 | 2.73 | 9.99% | 0.03 | 13.01% | 2.07 | 1.38% | 1.37 | 9.46 |
| BHAGIRADHA CHEM & INDS L | 3,660.56 | 201.64 | 5.24 | 2.60% | 0.13 | 4.13% | 55.80 | 0.05% | 0.67 | 2.02 |
| BHARAT RASAYAN LTD | 2,225.31 | 15.27 | 1.75 | 11.43% | 0.00 | 15.51% | 751.19 | 0.04% | 0.98 | 85.99 |
Astec Lifesciences Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹381.30 | ₹458.18 | ₹628.17 | ₹676.57 |
| Other Income | ₹5.63 | ₹5.64 | ₹13.06 | ₹10.47 |
| Total Revenue | ₹386.93 | ₹463.82 | ₹641.23 | ₹687.03 |
| Total Expenses | ₹527.92 | ₹525.57 | ₹606.28 | ₹565.91 |
| Profit Before Tax | -₹140.99 | -₹61.75 | ₹34.95 | ₹121.13 |
| Tax | -₹6.28 | -₹14.86 | ₹9.35 | ₹31.24 |
| Profit After Tax | -₹134.71 | -₹46.89 | ₹25.59 | ₹89.88 |
| EPS - Basic | -₹68.71 | -₹23.93 | ₹13.04 | ₹45.87 |
| EPS - Diluted | -₹68.71 | -₹23.93 | ₹13.04 | ₹45.85 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹140.99 | -₹61.75 | ₹34.95 | ₹121.13 |
| Income before WC changes | -₹39.92 | ₹1.69 | ₹85.45 | ₹165.14 |
| Change in Assets | ₹35.32 | ₹101.00 | ₹10.12 | -₹182.22 |
| Change in Liabilities | -₹8.80 | -₹90.50 | -₹16.03 | ₹69.83 |
| Change in WC | ₹26.53 | ₹10.49 | -₹5.91 | -₹112.39 |
| Cash flow from Operations | -₹8.40 | ₹10.22 | ₹74.66 | ₹23.60 |
| Cash flow from Investing | -₹15.23 | -₹135.18 | -₹112.51 | -₹103.87 |
| Cash flow from Financing | ₹23.73 | ₹124.96 | ₹37.77 | ₹80.48 |
| Total Cash Flow | ₹0.10 | ₹0.00 | -₹0.08 | ₹0.22 |
| Cash (Start of the year) | ₹0.47 | ₹0.47 | ₹0.55 | ₹0.34 |
| Cash (End of the year) | ₹0.58 | ₹0.47 | ₹0.47 | ₹0.55 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹540.29 | ₹576.44 | ₹480.56 | ₹381.08 |
| Current Assets | ₹341.14 | ₹398.49 | ₹498.85 | ₹515.68 |
| Total Assets | ₹881.42 | ₹974.93 | ₹979.41 | ₹896.76 |
| Current Liabilities | ₹365.71 | ₹397.16 | ₹526.20 | ₹490.59 |
| Net Current Asset | -₹24.57 | ₹1.33 | -₹27.35 | ₹25.09 |
| Non-Current Liabilities | ₹280.69 | ₹208.25 | ₹33.66 | ₹9.51 |
| Equity Capital | ₹235.02 | ₹369.52 | ₹419.56 | ₹396.66 |
| Total Equity & Liabilities | ₹881.42 | ₹974.93 | ₹979.41 | ₹896.76 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹381.30 | ₹458.18 | ₹628.17 | ₹676.57 |
| Other Income | ₹5.56 | ₹5.58 | ₹13.04 | ₹10.46 |
| Total Revenue | ₹386.86 | ₹463.76 | ₹641.20 | ₹687.03 |
| Total Expenses | ₹527.98 | ₹525.64 | ₹606.35 | ₹565.99 |
| Profit Before Tax | -₹141.12 | -₹61.88 | ₹34.85 | ₹121.04 |
| Tax | -₹6.31 | -₹14.89 | ₹9.33 | ₹31.22 |
| Profit After Tax | -₹134.81 | -₹46.99 | ₹25.52 | ₹89.82 |
| EPS - Basic | -₹68.74 | -₹23.96 | ₹13.02 | ₹45.85 |
| EPS - Diluted | -₹68.74 | -₹23.96 | ₹13.02 | ₹45.83 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹141.12 | -₹61.88 | ₹34.85 | ₹121.04 |
| Income before WC changes | -₹39.91 | ₹1.70 | ₹85.46 | ₹165.15 |
| Change in Assets | ₹35.32 | ₹100.89 | ₹10.11 | -₹182.22 |
| Change in Liabilities | -₹8.83 | -₹90.53 | -₹16.39 | ₹69.61 |
| Change in WC | ₹26.48 | ₹10.36 | -₹6.28 | -₹112.61 |
| Cash flow from Operations | -₹8.39 | ₹10.13 | ₹74.32 | ₹23.41 |
| Cash flow from Investing | -₹15.13 | -₹134.98 | -₹112.07 | -₹103.57 |
| Cash flow from Financing | ₹23.62 | ₹124.85 | ₹37.66 | ₹80.37 |
| Total Cash Flow | ₹0.10 | ₹0.00 | -₹0.09 | ₹0.22 |
| Cash (Start of the year) | ₹0.46 | ₹0.46 | ₹0.54 | ₹0.33 |
| Cash (End of the year) | ₹0.57 | ₹0.46 | ₹0.46 | ₹0.54 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹540.46 | ₹576.67 | ₹480.75 | ₹381.33 |
| Current Assets | ₹339.96 | ₹397.48 | ₹498.09 | ₹515.38 |
| Total Assets | ₹880.42 | ₹974.15 | ₹978.85 | ₹896.71 |
| Current Liabilities | ₹365.69 | ₹397.25 | ₹526.33 | ₹491.07 |
| Net Current Asset | -₹25.73 | ₹0.23 | -₹28.23 | ₹24.31 |
| Non-Current Liabilities | ₹280.66 | ₹208.22 | ₹33.73 | ₹9.66 |
| Equity Capital | ₹234.07 | ₹368.68 | ₹418.79 | ₹395.98 |
| Total Equity & Liabilities | ₹880.42 | ₹974.15 | ₹978.85 | ₹896.71 |
About Astec Lifesciences
Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company undertakes contract development and manufacturing services for a diverse range of agrochemicals. The Company operates through a single segment, namely Agrochemicals. Its product categories include Fungicide, Growth Regulator, Intermediates, Insecticide, and Herbicide. Its products include Azimsulfuron, Halosulfuron, Flutriafol, Rimsulfuron, Transfluthrin, Prothiaconazole, Metalaxyl, Cyproconazole, and Tribenuron methyl. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries, including the United States and countries across Europe, West Asia, South-East Asia, Latin America and Africa. The Company has approximately nine manufacturing plants, which are located in Maharashtra.
Astec Lifesciences Financial Highlights
- Revenue: Astec Lifesciences reported revenue of ₹453.22 crore in FY26 vs ₹386.93 crore in FY25. It showed an increase of 17.13% on a yearly basis.
- Operating Profit: Astec Lifesciences reported an operating loss of ₹81.00 crore in FY26 vs ₹140.99 crore in FY25. It showed an increase of 42.55% on a year-on-year basis.
- Net Profit: Astec Lifesciences reported a net loss of ₹80.88 crore in FY26 vs ₹134.71 crore in FY25. It showed an increase of 39.96% on a yearly basis.
Astec Lifesciences Quarterly Result Highlights
- Astec Lifesciences reported revenue of ₹161.25 crore in Mar 2026, compared with ₹125.54 crore in Dec 2025, representing an increase of 28.45% on a quarter-on-quarter (QoQ) basis.
- Astec Lifesciences reported an operating loss of ₹7.90 crore in Mar 2026, compared with ₹15.68 crore in Dec 2025, representing an increase of 49.62% on a quarter-on-quarter (QoQ) basis.
- Astec Lifesciences reported a loss of ₹7.75 crore in Mar 2026, compared with ₹15.69 crore in Dec 2025, reflecting an increase of 50.61% on a QoQ basis.
- The earnings per share (EPS) of Astec Lifesciences stood at ₹68.71 during Mar 2026.
Similar Stocks
FAQs on Astec Lifesciences Share Price
What is Astec Lifesciences share price today?
Astec Lifesciences share price is ₹709.90 as on 03 Jul, 2026, 15:55 IST.
How has the Astec Lifesciences share price performed in the past?
In the last 1 year, Astec Lifesciences delivered a return of -25.08%. The Astec Lifesciences share price hit a high of ₹947.70 and low of ₹513.40.
How much is the Mutual Fund shareholding in Astec Lifesciences shares?
The Mutual Fund Shareholding in Astec Lifesciences was 3.02% at the end of Mar 2026.
What is the the 52-week high and low of Astec Lifesciences shares ?
The 52-week high and low of Astec Lifesciences share is ₹947.70 and ₹513.40 as of 03 Jul, 2026.
What is the market cap of Astec Lifesciences?
The market capitalisation of Astec Lifesciences is ₹1,619.85 Crores as on 03 Jul, 2026.
What are the stock symbols of Astec Lifesciences?
The stock symbol of Astec Lifesciences is ASTEC on the NSE, 533138 on the BSE, and the ISIN is INE563J01010.
What was yesterday's closing price of Astec Lifesciences shares ?
Astec Lifesciences shares closed yesterday at ₹721.95 on NSE & ₹726.95 on BSE
How to buy Astec Lifesciences shares?
To buy Astec Lifesciences shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Astec Lifesciences shares on Holidays?
No, shares of Astec Lifesciences or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Astec Lifesciences shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Astec Lifesciences?
The PE and PB ratio of Astec Lifesciences is -20.03 and 4.15 respectively, as on 03 Jul, 2026, 15:55 IST.